Prospective evaluation of hot flashes during treatment with parenteral estrogen or complete androgen ablation for metastatic carcinoma of the prostate

Journal of Urology

Volumn 166, Issue 2, 2001, Pages 517-520

  Spetz, Anna Clara ^a   Hammar, Mats ^b   Lindberg, Bengt ^b   Spångberg, Anders ^b   Varenhorst, Eberhard ^b  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Androgens; Estrogens; Hot flashes; Prostate; Prostatic neoplasms

Indexed keywords

ANDROGEN; ESTROGEN; FLUTAMIDE; GONADORELIN DERIVATIVE; POLYESTRADIOL PHOSPHATE; TRIPTORELIN;

ARTICLE; CANCER HORMONE THERAPY; CASTRATION; DISTRESS SYNDROME; DRUG INDUCED DISEASE; FOLLOW UP; HOT FLUSH; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METASTASIS; ORCHIECTOMY; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR GROWTH;

EID: 0034941019     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)65973-3     Document Type: Article

References (22)

1. Prostate carcinoma trends in three counties in Sweden 1987-1996: Results from a population-based national cancer register
2. Prostate cancer: Metastatic
3. Androgen suppression by a gonadotropin releasing hormone analogue in patients with metastatic carcinoma of the prostate
4. Comparison of goserelin and leuprolide in combined androgen blockade therapy
5. Studies on prostatic cancer II. The effect of castration of advanced carcinoma of the prostate gland
6. Orchiectomy versus long-acting D-Trp-6-LHRH in advanced prostatic cancer
7. Phase III studies to compare goserelin (Zoladex) with orchiectomy and with diethylstilboestrol in treatment of prostatic carcinoma
8. Pathophysiology of hot flashes
9. Measurement of skin blood-flow and water evaporation as a means of objectively assessing hot flushes after orchiectomy in patients with prostatic cancer
10. Laboratory and ambulatory monitoring of menopausal hot flashes
11. Prevalence and duration of hot flushes after surgical or medical castration in men with prostatic carcinoma
12. Flushing. Long-term side effect of orchiectomy in treatment of prostatic carcinoma
13. Comparison of a long-acting LHRH agonist and polyestradiol phosphate in the treatment of advanced prostatic carcinoma: An open prospective, randomized multicentre study
14. Parenteral estrogen versus total androgen ablation in the treatment of advanced prostate carcinoma: Effects on overall survival and cardiovascular mortality
15. Orchiectomy versus oestrogen in the treatment of advanced prostatic cancer
16. Estrogens in the treatment of prostate cancer
17. Leuprolide versus diethylstilbestrol for metastatic prostate cancer
18. EORTC PROTOCOL 30805: A phase III trial comparing orchiectomy and cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate
19. Diethylstilbestrol in treatment of postorchiectomy vasomotor symptoms and its relationship with serum follicle-stimulating hormone, luteinizing hormone, and testosterone
20. Postmenopausal hot flushes and their management
21. Single drug polyestradiolphosphate therapy in prostatic cancer
22. Endocrine effects of combined treatment with a LHR agonist in association with flutamide in metastatic prostatic carcinoma